We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Mutations Cause Parkinson's Disease

By Biotechdaily staff writers
Posted on 01 Dec 2004
A gene and six mutations that cause symptoms associated with Parkinson's disease and other neurodegenerative disorders have been discovered by researchers. More...
Their findings were reported in the November 18, 2004, issue of Neuron.

The team of researchers found a mutation of the LRRK2 gene in members of six families with many individuals affected by Parkinson's disease. A brain autopsy on deceased members indicated that mutations in the LRRK2 gene play a central role in developing pathology characteristic of Parkinson's disease and similar disorders, such as Alzheimer's disease and amyotrophic lateral sclerosis, known as Lou Gehrig's disease.

Dr. ZbigniewWszolek, a neurologist at the Mayo Clinic Jacksonville (FL, USA), has studied the two largest families in which a LRRK2 mutation was found for the past 14 years. "The discovery of this gene will have major implications for the understanding of mechanisms leading to the development of these neurodegenerative diseases,” he remarked.

The discovery is the result of research into the cause of autosomal dominant, late-onset Parkinson's disease in the studied families. The Mayo team and other researchers have previously narrowed the genetic cause of this form of inherited parkinsonism to a region of chromosome 12 called PARK8.



Related Links:
Mayo Clinic Jacksonville

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.